Table 2: Incidence and relative
risk for vaccine completion for women ages 14-26 years who received human
papillomavirus vaccine from 2010-2012 (n = 201).
Variable |
n (%) |
RR (95% CI) |
|
Completers |
Non-Completers |
||
Demographic |
|
||
Race/Ethnicity |
|||
Non-Hispanic Black |
39 (28.2) |
99 (71.7) |
1 |
Non-Hispanic White |
4 (23.5) |
13 (76.4) |
0.83 (0.33-2.04) |
Hispanic |
16 (45.7) |
19 (54.2) |
1.61 (1.03-2.53)* |
Others |
4 (36.3) |
7 (63.6) |
1.28 (0.56-2.93) |
Age (in years) |
|||
14-19 |
8 (17.3) |
38 (82.6) |
1 |
20-22 |
25 (32.8) |
51 (67.1) |
1.89 (0.93-3.83) |
23-24 |
15 (34.8) |
28 (65.1) |
2.00 (0.94-4.24) |
25-26 |
15 (41.6) |
21 (58.3) |
2.39 (1.14-5.01)* |
Insurance Statusa |
|||
Self-Pay |
39 (33.3) |
78 (66.6) |
1 |
Private |
1 (16.6) |
5 (83.3) |
0.50 (0.08-3.04) |
Public |
16 (26.2) |
45 (73.7) |
0.78 (0.48-1.28) |
Medical/Obstetric history |
|||
Contraceptive Usea |
|||
Tier 1 |
5 (25.0) |
15 (75.0) |
0.96 (0.41-2.24) |
Tier 2 |
21 (25.9) |
60 (74.0) |
1 |
Tier 3 |
12 (37.5) |
20 (62.5) |
1.44 (0.81-2.58) |
Recent STIa |
|||
No |
48 (30.0) |
112 (70.0) |
1 |
Yes |
10 (33.3) |
20 (66.6) |
1.11 (0.63-1.94) |
Paritya |
|||
0 |
44 (32.5) |
91 (67.4) |
1 |
1 |
10 (24.3) |
31 (75.6) |
0.74 (0.41-1.35) |
≥ 2 |
6 (33.3) |
12 (66.6) |
1.02 (0.50-2.05) |
Visit type at the
first dosea |
|||
Condition-Oriented |
15 (27.2) |
40 (72.7) |
1 |
Contraceptive Management |
29 (36.2) |
51 (63.7) |
1.32 (0.79-2.23) |
Immunization |
7 (29.1) |
17 (70.8) |
1.06 (0.50-2.28) |
Preventive |
11 (30.5) |
25 (69.4) |
1.12 (0.58-2.15) |
aMissing values-17 for
insurance status, 68 for contraceptive use, 11 for recent STI, 7 for parity, 6
for visit type at first dose.
RR: Relative
Risk, CI: Confidence Interval, *p < 0.05